Chiara Cattaneo

7.3k total citations
102 papers, 2.2k citations indexed

About

Chiara Cattaneo is a scholar working on Oncology, Genetics and Hematology. According to data from OpenAlex, Chiara Cattaneo has authored 102 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 31 papers in Genetics and 28 papers in Hematology. Recurrent topics in Chiara Cattaneo's work include Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (23 papers) and Chronic Lymphocytic Leukemia Research (19 papers). Chiara Cattaneo is often cited by papers focused on Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (23 papers) and Chronic Lymphocytic Leukemia Research (19 papers). Chiara Cattaneo collaborates with scholars based in Italy, United States and Germany. Chiara Cattaneo's co-authors include Giuseppe Rossi, Alessandro Re, Erika Borlenghi, Salvatore Casari, Livio Pagano, Krijn K. Dijkstra, Anna Candoni, Sander Kelderman, Stieneke van den Brink and Lorenzo F. Fanchi and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Chiara Cattaneo

93 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Cattaneo Italy 25 1.3k 553 453 387 347 102 2.2k
Annamaria Nosari Italy 21 960 0.8× 898 1.6× 241 0.5× 813 2.1× 229 0.7× 52 2.0k
Thomas Gastinne France 26 1.4k 1.1× 305 0.6× 814 1.8× 374 1.0× 636 1.8× 127 3.0k
Anna Candoni Italy 31 804 0.6× 955 1.7× 527 1.2× 926 2.4× 1.1k 3.3× 153 3.5k
Tsiporah B. Shore United States 27 919 0.7× 516 0.9× 322 0.7× 345 0.9× 870 2.5× 152 2.3k
A. W. Dekker Netherlands 29 1.2k 0.9× 646 1.2× 400 0.9× 364 0.9× 1.5k 4.4× 66 3.0k
Tsila Zuckerman Israel 24 604 0.5× 410 0.7× 205 0.5× 222 0.6× 945 2.7× 125 2.5k
G Todeschini Italy 19 764 0.6× 264 0.5× 498 1.1× 214 0.6× 391 1.1× 32 1.6k
Luana Fianchi Italy 28 565 0.4× 772 1.4× 136 0.3× 687 1.8× 778 2.2× 91 2.3k
Simon Daenen Netherlands 29 695 0.5× 563 1.0× 120 0.3× 462 1.2× 1.0k 3.0× 78 2.5k
Isidro Jarque Spain 27 661 0.5× 739 1.3× 438 1.0× 461 1.2× 1.1k 3.2× 156 2.6k

Countries citing papers authored by Chiara Cattaneo

Since Specialization
Citations

This map shows the geographic impact of Chiara Cattaneo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Cattaneo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Cattaneo more than expected).

Fields of papers citing papers by Chiara Cattaneo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Cattaneo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Cattaneo. The network helps show where Chiara Cattaneo may publish in the future.

Co-authorship network of co-authors of Chiara Cattaneo

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Cattaneo. A scholar is included among the top collaborators of Chiara Cattaneo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Cattaneo. Chiara Cattaneo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Menna, Pierantonio, Francesco Marchesi, Chiara Cattaneo, et al.. (2023). Posaconazole and midostaurin in patients with FLT3‐mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study. Clinical and Translational Science. 16(10). 1876–1885. 3 indexed citations
3.
Belotti, Angelo, Rossella Ribolla, Claudia Crippa, et al.. (2023). Predictive role of sustained imaging MRD negativity assessed by diffusion‐weighted whole‐body MRI in multiple myeloma. American Journal of Hematology. 98(9). E230–E232. 5 indexed citations
4.
Pagano, Livio, et al.. (2020). Isavuconazole—Animal Data and Clinical Data. Journal of Fungi. 6(4). 209–209. 8 indexed citations
5.
Nadali, Gianpaolo, Anna Candoni, Chiara Cattaneo, et al.. (2020). Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective study. Leukemia & lymphoma. 61(12). 3002–3005. 1 indexed citations
6.
Sacco, Antonio, Cinzia Federico, Arianna Giacomini, et al.. (2020). Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88. Blood. 137(18). 2495–2508. 6 indexed citations
7.
Re, Alessandro, Chiara Cattaneo, & Silvia Montoto. (2020). Treatment management of haematological malignancies in people living with HIV. The Lancet Haematology. 7(9). e679–e689. 23 indexed citations
8.
Borlenghi, Erika, Chiara Pagani, Patrizia Zappasodi, et al.. (2020). Validation of the “fitness criteria” for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL). Journal of Geriatric Oncology. 12(4). 550–556. 13 indexed citations
9.
Re, Alessandro, Chiara Cattaneo, & Giuseppe Rossi. (2019). HIV AND LYMPHOMA: FROM EPIDEMIOLOGY TO CLINICAL MANAGEMENT. Mediterranean Journal of Hematology and Infectious Diseases. 11(1). e2019004–e2019004. 45 indexed citations
10.
11.
Ferreri, Andrés J.M., Michele Spina, Chiara Cattaneo, et al.. (2017). Safety and Activity of a Dose-Dense Short-Term Chemoimmunotherapy in HIV-Positive Patients with Burkitt Lymphoma (HIV-BL pts): Final Results of the Carmen Phase II Trial. Blood. 130. 2828–2828. 1 indexed citations
13.
Cattaneo, Chiara, Mario Tumbarello, Cristina Skert, et al.. (2013). Relapsing bloodstream infections during treatment of acute leukemia. Annals of Hematology. 93(5). 785–790. 17 indexed citations
14.
Cattaneo, Chiara, Morena Caira, Carlo Castagnola, et al.. (2013). Nocardia spp infections among hematological patients: results of a retrospective multicenter study. International Journal of Infectious Diseases. 17(8). e610–e614. 36 indexed citations
15.
Nosari, A., Morena Caira, Rosa Fanci, et al.. (2012). Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections. Clinical Microbiology and Infection. 19(8). 757–762. 25 indexed citations
16.
Pagano, Livio, Caterina Giovanna Valentini, Alessandro Pulsoni, et al.. (2012). Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 98(2). 239–246. 208 indexed citations
17.
Cattaneo, Chiara, Suzanne M. de la Monte, Alessandra Algarotti, et al.. (2011). A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study). Journal of Antimicrobial Chemotherapy. 66(9). 2140–2145. 24 indexed citations
19.
Cattaneo, Chiara, Pierangelo Spedini, Salvatore Casari, et al.. (2006). Delayed-onset peripheral blood cytopenia after rituximab: Frequency and risk factor assessment in a consecutive series of 77 treatments. Leukemia & lymphoma. 47(6). 1013–1017. 85 indexed citations
20.
Ghidini, Claudia, Alessandro Re, Chiara Cattaneo, et al.. (2005). T-Cell Immune Reconstitution after Hematopoietic Stem Cell Transplantation for HIV-Associated Lymphoma. Transplantation. 80(5). 673–682. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026